123 related articles for article (PubMed ID: 25843797)
1. DEPTOR-related mTOR suppression is involved in metformin's anti-cancer action in human liver cancer cells.
Obara A; Fujita Y; Abudukadier A; Fukushima T; Oguri Y; Ogura M; Harashima S; Hosokawa M; Inagaki N
Biochem Biophys Res Commun; 2015 May; 460(4):1047-52. PubMed ID: 25843797
[TBL] [Abstract][Full Text] [Related]
2. Regulation of human mTOR complexes by DEPTOR.
Wälchli M; Berneiser K; Mangia F; Imseng S; Craigie LM; Stuttfeld E; Hall MN; Maier T
Elife; 2021 Sep; 10():. PubMed ID: 34519268
[TBL] [Abstract][Full Text] [Related]
3. Bipartite binding and partial inhibition links DEPTOR and mTOR in a mutually antagonistic embrace.
Heimhalt M; Berndt A; Wagstaff J; Anandapadamanaban M; Perisic O; Maslen S; McLaughlin S; Yu CW; Masson GR; Boland A; Ni X; Yamashita K; Murshudov GN; Skehel M; Freund SM; Williams RL
Elife; 2021 Sep; 10():. PubMed ID: 34519269
[TBL] [Abstract][Full Text] [Related]
4. Metformin in Esophageal Carcinoma: Exploring Molecular Mechanisms and Therapeutic Insights.
Papadakos SP; Argyrou A; Lekakis V; Arvanitakis K; Kalisperati P; Stergiou IE; Konstantinidis I; Schizas D; Koufakis T; Germanidis G; Theocharis S
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474224
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanism of action of metformin: old or new insights?
Rena G; Pearson ER; Sakamoto K
Diabetologia; 2013 Sep; 56(9):1898-906. PubMed ID: 23835523
[TBL] [Abstract][Full Text] [Related]
6. Loss of tyrosine catabolic enzyme HPD promotes glutamine anaplerosis through mTOR signaling in liver cancer.
Tong M; Wong TL; Zhao H; Zheng Y; Xie YN; Li CH; Zhou L; Che N; Yun JP; Man K; Lee TK; Cai Z; Ma S
Cell Rep; 2021 Aug; 36(8):109617. PubMed ID: 34433044
[TBL] [Abstract][Full Text] [Related]
7. The anti-inflammatory effect of metformin: The molecular targets.
Sakata N
Genes Cells; 2024 Mar; 29(3):183-191. PubMed ID: 38311861
[TBL] [Abstract][Full Text] [Related]
8. Antitumor Activity of Metformin Combined with Locoregional Therapy for Liver Cancer: Evidence and Future Directions.
Choksi EJ; Elsayed M; Kokabi N
Cancers (Basel); 2023 Sep; 15(18):. PubMed ID: 37760509
[TBL] [Abstract][Full Text] [Related]
9. Lac-Phe mediates the anti-obesity effect of metformin.
Xiao S; Li VL; Lyu X; Chen X; Wei W; Abbasi F; Knowles JW; Deng S; Tiwari G; Shi X; Zheng S; Farrell L; Chen ZZ; Taylor KD; Guo X; Goodarzi MO; Wood AC; Ida Chen YD; Lange LA; Rich SS; Rotter JI; Clish CB; Tahir UA; Gerszten RE; Benson MD; Long JZ
bioRxiv; 2023 Nov; ():. PubMed ID: 37961394
[TBL] [Abstract][Full Text] [Related]
10. Genetically Proxied Therapeutic Effect of Metformin Use, Blood Pressure, and Hypertension's Risk: a Drug Target-Based Mendelian Randomization Study.
Jiang J; Hu D; Zhang Q; Lin Z;
J Cardiovasc Transl Res; 2023 Nov; ():. PubMed ID: 38012470
[TBL] [Abstract][Full Text] [Related]
11. Insights into the action of the pharmaceutical metformin: Targeted inhibition of the gut microbial enzyme agmatinase.
Tassoulas LJ; Wackett LP
iScience; 2024 Feb; 27(2):108900. PubMed ID: 38318350
[TBL] [Abstract][Full Text] [Related]
12. Metformin suppresses SARS-CoV-2 in cell culture.
Parthasarathy H; Tandel D; Siddiqui AH; Harshan KH
Virus Res; 2023 Jan; 323():199010. PubMed ID: 36417940
[TBL] [Abstract][Full Text] [Related]
13. Metformin: The Winding Path from Understanding Its Molecular Mechanisms to Proving Therapeutic Benefits in Neurodegenerative Disorders.
Isop LM; Neculau AE; Necula RD; Kakucs C; Moga MA; Dima L
Pharmaceuticals (Basel); 2023 Dec; 16(12):. PubMed ID: 38139841
[TBL] [Abstract][Full Text] [Related]
14. Metformin: From Diabetes to Cancer-Unveiling Molecular Mechanisms and Therapeutic Strategies.
Amengual-Cladera E; Morla-Barcelo PM; Morán-Costoya A; Sastre-Serra J; Pons DG; Valle A; Roca P; Nadal-Serrano M
Biology (Basel); 2024 Apr; 13(5):. PubMed ID: 38785784
[TBL] [Abstract][Full Text] [Related]
15. Shifting the Soil: Metformin Treatment Decreases the Protumorigenic Tumor Microenvironment in Epithelial Ovarian Cancer.
Taylor SE; Chan DK; Yang D; Bruno T; Lieberman R; Siddiqui J; Soong TR; Coffman L; Buckanovich RJ
Cancers (Basel); 2022 May; 14(9):. PubMed ID: 35565427
[TBL] [Abstract][Full Text] [Related]
16. Metformin Attenuates Neutrophil Recruitment through the H3K18 Lactylation/Reactive Oxygen Species Pathway in Zebrafish.
Zhou R; Ding RC; Yu Q; Qiu CZ; Zhang HY; Yin ZJ; Ren DL
Antioxidants (Basel); 2024 Jan; 13(2):. PubMed ID: 38397774
[TBL] [Abstract][Full Text] [Related]
17. Metformin Treatment of Macrophages Increases Microvessel Growth in Three-Dimensional Hydrogel Coculture.
Silberman J; Olagbiyan M; Moore E
Tissue Eng Part A; 2024 Mar; ():. PubMed ID: 38308479
[TBL] [Abstract][Full Text] [Related]
18. Metformin derivatives - Researchers' friends or foes?
Torunoglu ST; Zajda A; Tampio J; Markowicz-Piasecka M; Huttunen KM
Biochem Pharmacol; 2023 Sep; 215():115743. PubMed ID: 37591450
[TBL] [Abstract][Full Text] [Related]
19. Systematic Investigation of Dose-Dependent Protein Thermal Stability Changes to Uncover the Mechanisms of the Pleiotropic Effects of Metformin.
Yin K; Wu R
ACS Pharmacol Transl Sci; 2024 Feb; 7(2):467-477. PubMed ID: 38357277
[TBL] [Abstract][Full Text] [Related]
20. Metformin inhibits growth of human glioblastoma cells and enhances therapeutic response.
Sesen J; Dahan P; Scotland SJ; Saland E; Dang VT; Lemarié A; Tyler BM; Brem H; Toulas C; Cohen-Jonathan Moyal E; Sarry JE; Skuli N
PLoS One; 2015; 10(4):e0123721. PubMed ID: 25867026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
